ÂÜÀòÂÒÂ×

Philip Song is an experienced equity research professional with a focus on the healthcare sector, specifically in life science tools and diagnostics at Leerink Partners since May 2022. Previously, Philip served as an equity research analyst at Melius Research, covering the industrials sector, including various well-known companies. Earlier career roles included a research associate position at SparkLabs Group and internships with the Office of the Massachusetts Governor and the Massachusetts State Senate. Philip Song holds a degree in International Relations and International Finance from Tufts University and has also studied at The London School of Economics and Political Science, complemented by education at Westminster School.